Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2005
09/20/2005US6946544 XAF genes and polypeptides: methods and reagents for modulating apoptosis
09/20/2005US6946543 Truncated EGF receptor
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946296 Methods and compositions for polypeptide engineering
09/20/2005US6946278 Serine proteases inhibitors comprising chymostrypsin site from transgenic plants; insect resistance
09/20/2005US6946272 Transition state analogs
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
09/20/2005US6946261 gene expression cassettes comprising promoters joined to nucleic acids that code fusion proteins; peptide antibiotics; genetic engineering
09/20/2005US6946255 Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof
09/20/2005US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005CA2189882C Papillomavirus vaccines
09/20/2005CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
09/15/2005WO2005085464A1 Methods to make and use antibodies of improved cross-reactivity
09/15/2005WO2005085433A1 Method of regulating o-glycosylation in eucaryotic cell
09/15/2005WO2005085288A2 Natural igm antibodies and inhibitors thereof
09/15/2005WO2005056569A3 Beta integrin gene and protein
09/15/2005WO2005034841A3 Anthrax vaccine
09/15/2005WO2005016232A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/15/2005WO2005000099A3 BLOOD FACTOR DOMAINS (BFDs)
09/15/2005WO2003000844A3 Protein modification and maintenance molecules
09/15/2005US20050204429 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds
09/15/2005US20050204422 Using vector transformation to express antisense sequences which suppress phytoene desaturase activity and enhance phytoene concentration in plant
09/15/2005US20050204412 Artery- and vein-specific proteins and uses therefor
09/15/2005US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins
09/15/2005US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor
09/15/2005US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor
09/15/2005US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
09/15/2005US20050203020 Safe drug administration carrier capable of extending the half life of a drug in the blood without the risk of contamination of viruses
09/15/2005US20050203012 Human parathyroid hormone modifications, preparation and use
09/15/2005US20050203004 Pharmacologically active polypeptide glycoconjugates
09/15/2005US20050202544 Nucleotide sequences coding benzoic/anthranilic acid regulatory sequences in tandem; gene transfer vector for improving heterologous gene expression
09/15/2005US20050202540 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene
09/15/2005US20050202539 System for screening eukaryotic membrane proteins
09/15/2005US20050202537 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
09/15/2005US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders
09/15/2005US20050202529 Humanised antibodies
09/15/2005US20050202528 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof
09/15/2005US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202517 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
09/15/2005US20050202512 Immunoglobulins; libraries; antibodies; complementary determining regions; immunoassay
09/15/2005US20050202498 Linkers that provide enhanced affinity and specificity to chimeric zinc finger proteins
09/15/2005US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide
09/15/2005US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders
09/15/2005US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate)
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses
09/15/2005US20050202040 Methods for large scale productions of recombinant DNA-derived tPA or K2S molecules
09/15/2005US20050202024 Protein sequences containing antigenized antibodies for foot-and-mouth disease
09/15/2005US20050202022 Polynucleotides encoding humanized antibodies against human 4-1BB
09/15/2005US20050202021 Anti-cancer antibodies with reduced complement fixation
09/15/2005US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005CA2560066A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2557788A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005CA2557353A1 Immunogenic compositions for chlamydia pneunomiae
09/15/2005CA2553734A1 Rna-dependent dna polymerase from geobacillus stearothermophilus
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574521A1 Method of protecting thiol group of protein
09/14/2005EP1573314A2 Transgenic mice expressing human cd20
09/14/2005EP1573313A2 Transgenic mice expressing human cd20 and/or cd16
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572983A1 Culture chamber for biologicals
09/14/2005EP1572981A1 Mutations affecting plasmid copy number
09/14/2005EP1572971A2 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
09/14/2005EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use
09/14/2005EP1572967A2 Il-1 receptor based antagonists and methods of making and using
09/14/2005EP1572941A2 Novel flavivirus antigens
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/14/2005EP1572921A2 Cytokine polypeptides
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572912A2 Selection free growth of host cells containing multiple integrating vectors
09/14/2005EP1572910A2 Signal for packaging of influenza virus vectors
09/14/2005EP1572908A2 Chimeric molecules for cleavage in a treated host
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572900A2 Antibodies directed to pdgfd and uses thereof
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572897A2 Ordered biological nanostructures formed from chaperonin polypeptides
09/14/2005EP1572895A2 Methods for producing hyaluronan in a recombinant host cell
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572883A2 Human cytokine receptor
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572871A2 T1r3 a novel taste receptor
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572861A2 Ap1 amine oxidase variants
09/14/2005EP1572720A2 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
1 ... 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 ... 1125